↓ Skip to main content

Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast…

Overview of attention for article published in BMC Cancer, October 2012
Altmetric Badge

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer
Published in
BMC Cancer, October 2012
DOI 10.1186/1471-2407-12-447
Pubmed ID
Authors

Malek B Hannouf, Bin Xie, Muriel Brackstone, Gregory S Zaric

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 18%
Student > Ph. D. Student 7 12%
Student > Doctoral Student 7 12%
Other 6 10%
Student > Master 4 7%
Other 12 20%
Unknown 13 22%
Readers by discipline Count As %
Medicine and Dentistry 18 30%
Nursing and Health Professions 4 7%
Agricultural and Biological Sciences 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Business, Management and Accounting 3 5%
Other 11 18%
Unknown 17 28%